AI-Driven Cardiovascular Diagnostics Company Brings Early Detection Technology to Capital Markets

Company Website: https://www.cboe.com/ca/equities/
TORONTO -- (Business Wire)

Cboe Canada Inc. (“Cboe Canada”) today announced the listing of GuideAI Health Corp. (“GuideAI”), an artificial intelligence healthcare company focused on improving the detection, management, and outcomes of vascular disease. The company's common shares are now available for trading on Cboe Canada, under the symbol GDAI.

GuideAI is developing an AI platform designed to transform complex medical imaging and clinical data into actionable diagnostic insights. Its mission is to make advanced cardiovascular diagnostic intelligence accessible to a broader range of healthcare providers beyond major academic and research centers.

"We are pleased to welcome GuideAI to Cboe Canada," said CEO, Joacim Wiklander. "Their work at the intersection of artificial intelligence and cardiovascular health represents exactly the kind of innovative, high-growth company that Canadian public markets should be supporting. We look forward to their continued growth as a publicly listed company."

The listing on Cboe Canada gives GuideAI access to an internationally recognized exchange with deep expertise in emerging sectors and a strong commitment to capital formation for innovative companies.

"Going public marks an important milestone for GuideAI as we scale our platform and broaden access to life-changing diagnostic technology," said Raj Shah, CEO of GuideAI Health Corp. "We are excited to join the Cboe Canada community and look forward to delivering on our mission for patients, clinicians, and shareholders alike."

Investors can trade shares of GDAI through their usual investment channels, including discount brokerages and full-service dealers. To explore all listed securities on Cboe Canada, click here.

Cboe Canada continues to attract innovative companies and asset managers by offering a streamlined listing process, competitive fee structure, and access to a diverse and engaged investor base. The exchange is home to leading Canadian and international growth companies, ETFs from Canada’s most reputable ETF issuers, and an expansive suite of Canadian Depositary Receipts (CDRs). Cboe Canada consistently facilitates close to 15% of all trading volume in Canadian listed securities.

About Cboe Canada

Cboe Canada is Canada’s senior stock exchange providing a best-in-class listing experience for issuers that are shaping the economies of tomorrow. Fully operational since 2015, Cboe Canada lists companies and investment products seeking a robust and internationally recognized platform that enables investor trust, quality liquidity, and broad awareness including unfettered access to market data.

Connect with Cboe Canada: Website |LinkedIn|X

About GuideAI Health Corp.

GuideAI Health Corp. is a healthcare technology company using artificial intelligence to enable the early detection of vascular disease and support more precise treatment decisions. Its platform analyzes routine CT scans to identify peripheral vascular disease. By surfacing disease earlier, GuideAI aims to improve patient outcomes while helping hospitals and radiology groups deliver more comprehensive vascular care.

Connect with GuideAI: Website | LinkedIn

View source version on businesswire.com: https://www.businesswire.com/news/home/20260629537146/en/

Contacts:

Cboe Canada Media Contact:
media@cboe.ca

Source: Cboe Canada Inc.